Mixed Connective Tissue Diseases

Mixed Connective Tissue Diseases Treatment at IRIS
Overlapping Autoimmune Disorder

Understanding Mixed Connective Tissue Diseases: Symptoms, Diagnosis & Advanced Care

Mixed Connective Tissue Disease (MCTD) is a rare autoimmune disorder that features overlapping features of several connective tissue diseases, including systemic lupus erythematosus, systemic sclerosis, and polymyositis. Unlike single autoimmune conditions, MCTD occurs when the immune system triggers a mixed pattern of inflammation affecting multiple organ systems. Early diagnosis and targeted treatment are crucial to managing symptoms, preventing organ damage, and improving quality of life. At IRIS Centre for Rheumatology, we offer world-class, patient-centric care for MCTD using the latest advances in rheumatology.

Mixed Connective Tissue Disease can affect anyone at any age, but it most commonly begins between the ages of 15 and 35. Women are affected much more frequently than men. The condition may also cause systemic inflammation affecting the skin, joints, muscles, lungs, heart, kidneys, and blood vessels. At IRIS, our multidisciplinary team ensures comprehensive management from early diagnosis to long-term remission strategies.

With our state-of-the-art immunodiagnostic laboratory, musculoskeletal ultrasound, and personalized treatment plans — including immunosuppressants and corticosteroids — we aim to halt disease progression, relieve symptoms, and restore quality of life. Healing begins with expert care and compassion.

Mixed Connective Tissue Diseases Symptoms

Common Symptoms of Mixed Connective Tissue Diseases

MCTD symptoms can vary in severity. Early recognition leads to better outcomes.

  • Raynaud's phenomenon (color changes in fingers/toes)
  • Joint pain, swelling, and stiffness (arthritis)
  • Swollen fingers (sausage-like appearance)
  • Muscle weakness (myositis component)
  • Skin rashes (lupus-like or scleroderma-like)
  • Difficulty swallowing and pulmonary hypertension

Diagnosis at IRIS

Early and accurate diagnosis is key to controlling MCTD. Our advanced diagnostic tools include:

  • Comprehensive clinical examination & symptom assessment
  • Blood tests: ANA, Anti-U1 RNP (high titers)
  • Musculoskeletal Ultrasound for joint and muscle inflammation
  • Pulmonary function tests and echocardiogram
  • EMG and muscle biopsy if myositis suspected

Advanced Treatment Options

We tailor treatments to achieve remission and improve life quality.

  • Corticosteroids for rapid flare control
  • Immunosuppressive agents (Mycophenolate, Methotrexate)
  • Vasodilators for Raynaud's phenomenon
  • Antimalarials (Hydroxychloroquine)
  • Physiotherapy for muscle and joint function
  • Patient education & regular organ monitoring

Why Choose IRIS for Mixed Connective Tissue Diseases Care?

  • Expert rheumatologists with 13+ years experience
  • ISO 9001:2015 Certified & NABH accredited lab
  • On-site musculoskeletal ultrasound & immunodiagnostics
  • Personalized immunosuppressive therapy monitoring
  • Integrated care for overlapping autoimmune features
  • Compassionate, patient-centric approach
  • Over 2000+ patients successfully treated
  • Multidisciplinary care for systemic involvement


IRIS Centre for Rheumatology Kollam